{"database": "lobbying", "table": "lobbying_activities", "rows": [[1844236, "00e57268-6b44-4bd9-bc0f-980fbf9fa4c3", "Q2", "HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC", 17966, "EMERGENT BIOSOLUTIONS", 2016, "second_quarter", "MED", "H.R. 4400 and S. 2512 (P.L. 114 - 146) - Adding Zika Virus to the FDA Priority Review Program Act - entire bill.", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2016-07-15T15:48:08.300000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1844236"], "units": {}, "query_ms": 0.46583206858485937, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}